References
1. Fokkens W, Landis B, Hopkins C, Reitsma S, Sedaghat A. Rhinology in review: from COVID-19 to biologicals. Rhinology. 2021.
2. Babaei A, Iravani K, Malekpour B, Golkhar B, Soltaniesmaeili A, Hosseinialhashemi M. Factors associated with anosmia recovery rate in COVID‐19 patients. Laryngoscope Investigative Otolaryngology.2021;6(6):1248-1255.
3. Gallo O, Locatello LG, Mazzoni A, Novelli L, Annunziato F. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection.Mucosal immunology. 2021;14(2):305-316.
4. Whitcroft K, Ezzat M, Cuevas M, Andrews P, Hummel T. The effect of intranasal sodium citrate on olfaction in post‐infectious loss: results from a prospective, placebo‐controlled trial in 49 patients.Clinical Otolaryngology. 2017;42(3):557-563.
5. Whitcroft K, Gunder N, Cuevas M, et al. Intranasal sodium citrate in quantitative and qualitative olfactory dysfunction: results from a prospective, controlled trial of prolonged use in 60 patients.European Archives of Oto-Rhino-Laryngology. 2021:1-7.
6. Hart JR. Ethylenediaminetetraacetic acid and related chelating agents. Ullmann’s encyclopedia of industrial chemistry. 2000.
7. Benes DM, Burnett CL. Final report on the safety assessment of pentasodium pentetate and pentetic acid as used in cosmetics.International journal of toxicology. 2008;27:71-92.
8. Sniffin’Sticks HT. Olfactory Performance Assessed by the Combined Testing of Odor Identification, Odor Discrimination and Olfactory Threshold. Chemical Senses. 1997;22(1):39-52.
9. Burke W. The ionic composition of nasal fluid and its function.Health. 2014;2014.
10. Švancara I, Vytřas K, Kalcher K, Walcarius A, Wang J. Carbon paste electrodes in facts, numbers, and notes: a review on the occasion of the 50‐years jubilee of carbon paste in electrochemistry and electroanalysis. Electroanalysis: An International Journal Devoted to Fundamental and Practical Aspects of Electroanalysis.2009;21(1):7-28.
11.Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common findings in COVID‐19 patients. The Laryngoscope.2020;130(7):1787-1787.
12. Gorzkowski V, Bevilacqua S, Charmillon A, et al. Evolution of olfactory disorders in COVID‐19 patients. The Laryngoscope.2020;130(11):2667-2673.
13. Saniasiaya J, Islam MA, Abdullah B. Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID‐19): A Meta‐analysis of 27,492 Patients. The Laryngoscope. 2021;131(4):865-878.
14. Ronnett GV, Moon C. G proteins and olfactory signal transduction.Annual review of physiology. 2002;64(1):189-222.
15. Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the “Sniffin’Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. European Archives of Oto-Rhino-Laryngology. 2007;264(3):237-243.
16. Rumeau C, Nguyen D, Jankowski R. How to assess olfactory performance with the Sniffin’Sticks test®. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2016;133(3):203-206.
Table 1: Patient’s characteristics